Mixed
Sarcopenic obesity is defined by the co-existence of excess adiposity and low skeletal muscle mass/function, requiring a two-step diagnostic algorithm of screening followed by functional and body composition assessment.
To identify sarcopenic obesity, first screen for high BMI or waist circumference. If positive, test muscle function (e.g., handgrip strength). If function is low, assess body composition (DXA or BIA) to confirm low muscle mass relative to fat. This two-step process ensures accurate diagnosis without unnecessary expensive testing for everyone.
The jointly appointed international expert panel proposes that SO is defined as the co-existence of excess adiposity and low muscle mass/function. The diagnosis of SO should be considered in at-risk individuals who screen positive for a co-occurring elevated body mass index or waist circumference, and markers of low skeletal muscle mass and function... Diagnostic procedures should initially include assessment of skeletal muscle function, followed by assessment of body composition where presence of excess adiposity and low skeletal muscle mass or related body compartments confirm the diagnosis of SO.
Why this rating
Based on a Delphi consensus process involving 38 international experts with 93.6% agreement.
Source
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Lorenzo M. Donini et al. · Obesity Facts · 2022
DOI 10.1159/000521241
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →